Skip to content

Phase I Study of Feasibility of Single Session Spine Stereotactic Radiosurgery (SSRS) in the Primary Management in Patients With Inoperable, Previously Unirradiated Metastatic Epidural Spinal Cord Compression (MESCC)

Phase I Study of Feasibility of Single Session Spine Stereotactic Radiosurgery (SSRS) in the Primary Management in Patients With Inoperable, Previously Unirradiated Metastatic Epidural Spinal Cord Compression (MESCC)

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01254903
Enrollment
43
Registered
2010-12-07
Start date
2010-12-03
Completion date
2027-04-01
Last updated
2026-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic Epidural Spinal Cord Compression

Keywords

Stereotactic Radiosurgery, Radiation, Radiotherapy, Metastatic Epidural Spinal Cord Compression, MESCC

Brief summary

The goal of this clinical study is to learn the feasibility of using a single session of radiation, known as spine stereotactic radiosurgery (SSRS), to treat metastatic epidural spinal cord compression.

Detailed description

Spinal cord compression is often treated with surgery followed by radiation in small doses everyday for a number of days. When a patient cannot or will not have surgery, radiation is given daily. With increased accuracy and precision, higher doses of radiation can be given in a single session. Giving a higher dose in a single session may increase the chance that the tumor will stop growing into the spinal canal and will prevent spinal cord injury. This study will also help to identify the tolerance of the spinal cord to radiation in a single session. Spine Stereotactic Radiosurgery: You will lie in the mold that was made for you for 45-120 minutes while you receive your radiation treatment. Follow-up Visits: You will have follow-up visits at Months 3 (+/-2 weeks ), 6 (+/-4 weeks), 9 (+/-4 weeks), 12 (+/-8 weeks), 18 (+/-8 weeks), and 24 (+/-8 weeks) and then every 6 months after that. At each follow-up visit: * Your medical history will be recorded, including any use of steroids. * You will have a neurological exam. * You will complete the 3 questionnaires about health, symptoms you may be having, and about pain. * You will have an MRI of the spine (except for Month 1). If you are unable to return for follow-up clinic visits, you will be called and asked about your medical history, and you will complete the 3 questionnaires about your health, symptoms you may be having, and about pain. This call should take about 20 minutes. Length of Study: Your treatment will last 1 day. You will continue having follow-up visits or phone calls for as long as possible. This is an investigational study. SSRS is FDA approved. The use of SSRS to treat metastatic epidural spinal cord compression is investigational. Up to 36 patients will take part in this study. All will be enrolled at M. D. Anderson.

Interventions

Target dose of 18 or 24 Gy to spine in single session of radiation treatment.

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Greater than or equal to 18 years old 2. Radiographically documented metastatic epidural compression on spine Magnetic resonance imaging (MRI) within 4 weeks of registration, defined radiographically, ranging from minimal canal compromise and thecal indentation to actual displacement of the spinal cord. 3. Maximum of 3 contiguous vertebral levels involved with metastasis in the spine to be irradiated in a single session 4. Signed Informed consent 5. Diagnosis of cancer (not one of the more radiosensitive histologies, see

Exclusion criteria

) including but not limited to non-small cell lung cancer, breast, prostate, renal cell, melanoma, gastrointestinal, sarcoma, thyroid, head and neck primary, and unknown primary tumors 6. Motor Strength \>/= 4 out of 5 in extremity or extremities affected by the level of the spinal cord compression 7. Karnofsky performance status (KPS) \>/= 40 8. Patients deemed to be inoperable by patient refusal, by neurosurgical evaluation, or for any reason

Design outcomes

Primary

MeasureTime frameDescription
Number of Occurrences of Paralysis caused by Radiation Myelitis (RM)Up to 12 months following radiationIncidence of patients who are ambulatory at baseline, 3 months and 6 months will be tabulated. Cases of patients who develop spinal cord myelopathy determined to be radiation related graded according to NCI CTC v4.0 scale.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAmol J. Ghia, MD

M.D. Anderson Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 17, 2026